Advertisement
Advertisement
APYX
Apyx Medical Corporation Common Stock
4.05
USDSponsored
-0.11
-2.64%
Aug 07, 15:59 UTC -4
Closed
After-Market
4.04
-0.01
-0.37%
APYX Earnings Reports
Positive Surprise Ratio
APYX beat 30 of 43 last estimates.
70%
Next Report
Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q2 26 (Revenue/ EPS)
--
/--
Implied change from Q-- -- (Revenue/ EPS)
--
/--
Apyx Medical Corporation Common Stock earnings per share and revenue
On Aug 06, 2026, APYX reported earnings of -0.07 USD per share (EPS) for Q2 26, beating the estimate of -0.08 USD, resulting in a 16.27% surprise. Revenue reached 13.88 million, compared to an expected 13.44 million, with a 3.28% difference. The market reacted with a -2.64% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Trulieve Cannabis Corp.
Report Date
Aug 07, 2026 For Q2 26
Estimate
$0.06
Actual
$0.11
Surprise
+72.14%
BioLife Solutions Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.03
Actual
$0.04
Surprise
+17.65%
Maravai LifeSciences Holdings, Inc. Class A Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.04
Actual
-$0.02
Surprise
+54.65%
Canopy Growth Corporation Common Shares
Report Date
Aug 07, 2026 For Q1 27
Estimate
-$0.11
Actual
-$0.02
Surprise
+75.74%
TriSalus Life Sciences, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.15
Actual
-$0.16
Surprise
-1.20%
ResMed Inc.
Report Date
Aug 06, 2026 For Q4 26
Estimate
$2.91
Actual
$2.95
Surprise
+1.09%
ICU Medical Inc
Report Date
Aug 06, 2026 For Q2 26
Estimate
$1.95
Actual
$2.37
Surprise
+21.43%
Haemonetics Corporation
Report Date
Aug 06, 2026 For Q1 27
Estimate
$1.08
Actual
$1.13
Surprise
+4.82%
United-Guardian, Inc.
Report Date
Aug 07, 2026 For Q2 26
Estimate
-Actual
$0.16
Surprise
-
Cytosorbents Corp.
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.04
Actual
-$0.07
Surprise
-52.51%
FAQ
What were Apyx Medical Corporation Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Apyx Medical Corporation Common Stock reported EPS of -$0.07, beating estimates by 16.27%, and revenue of $13.88M, 3.28% above expectations.
How did the market react to Apyx Medical Corporation Common Stock's Q2 2026 earnings?
The stock price moved down -2.64%, changed from $4.16 before the earnings release to $4.05 the day after.
When is Apyx Medical Corporation Common Stock expected to report next?
The next earning report is scheduled for --.
What are the forecasts for Apyx Medical Corporation Common Stock's next earnings report?
Based on --
analysts, Apyx Medical Corporation Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement